| About the author: |
Komnatska K. M., Chereshnyuk I. L., Khodakivskyi O. A., Prokopenko S. V. |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The article presents the results of screening studies the presence of neuroretinoprotection effect in Melatonin, Ademol, Citicoline, Mexidol, Corvitin and Thiotriazolin using immunoassay method for assessing activity in serum marker of neuronal destruction – neuron-specific enolase. It was established that all studied organoprotectors had native neucytoprotective activity in terms of the model of eye contusion caused by the action of carbon dioxide under pressure that is developed in the reliably de-escalation of activity investigated marker. The greatest protective effect was found in Melatonin and Ademol. Their therapeutic use in the proposed doses helps to preserve the integrity of retinal neurons in this condition. The data is the basis for the implementation of these drugs in ophthalmic practice for the practical treatment of traumatic lesions of the visual analyzer different genesis. |
| Tags |
melatonin, Ademol, neuroretinoprotection, eye contusion |
| Bibliography |
- Bespyatyih A. Yu. Melatonin: teoriya i praktika / A. Yu. Bespyatyih, V. Ya. Brodskiy, O. V. Burlakova [i dr.]. – M.: ID «MEDPRAKTIKA-M», 2009. – 99s.
- Gundorova R.A. Travmyi glaza / R. A. Gundorova, V. V. Neroev, V. V. Kashnikov. – M. : GEOTAR-Media. – 2014. – 560 s.
- Ivanitskaya E.V. Okklyuziya tsentralnoy arterii setchatki pri kontuzionnoy travme organa zreniya / E. V. Ivanitskaya, D. O. Peretyagina // Oftalmol. zhurnal.- 2012. – No. 2. – S.79-81.
- Nedzvetskaya O.V. Neotlozhnaya pomosch pri raneniyah i kontuziyah organa zreniya i ego pridatochnogo apparata (Lektsiya-konspekt dlya vrachey neotlozhnoy pomoschi, semeynyih vrachey, internov, vrachey-oftalmologov) / O. V. Nedzvetskaya // Meditsina neotlozhnyih sostoyaniy. – 2015. – No. 4. – S.9-21.
- Osborne N. N. Optic nerve and neuroprotection strategies / N. N. Osborne, G. Chidlow, C. J. Layton [et al.] // Eye. – 2004. – Vol. 18, № 11. – P. 1075–1084.
- Hodakivskiy O. A. Patogenetichne obgruntuvannya dotsilnosti vikoristannya novih pohidnih adamantanu pri eksperimentalniy terapiyi gostroyi ishemiyi golovnogo mozku ta miokarda (eksperimentalne doslidzhennya) : avtoref. dis. d. med. n. : spets. 14.03.05 – farmakologiya / O. A. Hodakivskiy. – Odesa., -2014. – 24 s.
- Hodakivska O. V. Tserebroprotektorna aktivnist novih pohidnih 3,2'-spiro-pirrolo-2-oksindolu v umovah ishemichnogo insultu (eksperimentalne doslidzhennya)»: avtoref. dis. k. med. n. : spets. 14.03.05 – farmakologIya / O. V. Hodakivska. – Harkiv, -2015. – 16 s.
- Melatonin Reduces the Expression of Excitotoxicity-Triggered Markers of Apoptosis / H. Manev, T. Uz, A. Kharlamov [et al.] // Therapeutic Potential of Melatonin. Front Horm Res. Basel, Karger. – 1997. – Vol 23. – P. 89-98.
- Rosenstein R. E. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis / R. E. Rosenstein, S. R. Pandi-Perumal, V. Srinivasan [et al.] // J. Pineal. Res. – 2010. - Vol. 49, № 1. – P.1-13.
- Simone F. Biotechnology, animal health and animal welfare within the framework of European Unionlegislation / F. Simone; J. Serratosa // Rev. Sci. Tech. Оіе. – 2005. – Vol. 24, №.1 – Р. 89-99.
|
| Publication of the article |
«World of Medicine and Biology» №4(58), 2016 year, 105-109 pages, index UDK 615.27:615.216.6/.8:577.17:615.356 |
